missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Dinutuximab Recombinant Monoclonal Antibody
GREENER_CHOICE

Recombinant Monoclonal Antibody

Brand:  Invitrogen™ MA559447

 Afficher plus de versions de ce produit

Code produit. 30283889

  • £397.00 / 100µg

Please to purchase this item. Need a web account? Register with us today!

Les retours ne sont pas autorisés pour ce produit. Afficher la politique du retour.

Description

Description

For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °.

Dinutuximab is an IgG1 monoclonal human/mouse chimeric antibody against GD2, a disialoganglioside expressed on tumors of neuroectodermal origin, including human neuroblastoma and melanoma, with highly restricted expression on normal tissues. It is composed of the variable heavy- and light-chain regions of the murine anti-GD2 mAb 14. 18 and the constant regions of human IgG1 heavy-chain and kappa light-chain. By binding to GD2, dinutiximab induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity of tumor cells thereby leading to apoptosis and inhibiting proliferation of the tumor. It is indicated, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy. Despite a high clinical response seen after first-line treatment, the complete eradication of neuroblastoma is rarely achieved and the majority of patients with advanced disease suffer a relapse. Current strategies for treatment include immunotherapy with pharmaceuticals such as dinutuximab to target surviving neuroblastoma cells and to prevent relapse.
TRUSTED_SUSTAINABILITY
Spécification

Spécification

Dinutuximab Chimeric
Recombinant Monoclonal
Unconjugated
MAb-14.18; MOAB Ch14.18
Protein A
RUO
Human
Antibody
IgG1 κ
ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance
1 mg/mL
25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2
Human
100 μg
Primary
-20°C, Avoid Freeze/Thaw Cycles
Lyophilized
Suggestions de produits

Suggestions de produits

Vidéos
FDS
Documents

Documents

Certificats
Promotions

Promotions

Correction du contenu d'un produit

Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.

Nom du produit

En cliquant sur Soumettre, vous reconnaissez que vous pouvez être contacté par Fisher Scientific au sujet des informations que vous avez fournies dans ce formulaire. Nous ne partagerons pas vos informations à d'autres fins. Toutes les informations de contact fournies seront également conservées conformément à notre politique de confidentialité. Politique de confidentialité.

Merci de nous aider à améliorer notre site web. Votre commentaire a été soumis